In its Q2 2022 investor letter, Baron Health Care Fund mentioned Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) and explained its insights for the company. Founded in 1989, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is a Boston, Massachusetts-based biopharmaceutical company with a $75.5 billion market capitalization. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) delivered a 34.12% return since the beginning of the year, while its 12-month returns are up by 51.53%. The stock closed at $294.52 per share on August 12, 2022.